Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra(TM) In Patients With Sepsis

Stock Information for Enlivex Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Enlivex Ltd.

Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors
Enlivex Announces $212,000,000 Private Placement to Initiate World's First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.